Written questions by Rosindell.

What steps he has taken to improve health outcomes for homeless people.

I refer the Hon. Member to the answer I gave on 17 July 2025 to Question 66125.

What steps he is taking to improve the health outcomes of veterans.

As well as being able to access all national health services across the United Kingdom, NHS England has also introduced several bespoke services to improve healthcare support available to veterans. These are: Op RESTORE which supports veterans with service-related physical health problems; Op COURAGE which supports veterans with a mental health pathway; and Op NOVA which supports veterans in the justice system.In addition, the veteran-aware trust and the veteran-friendly accreditation schemes raise awareness amongst healthcare professionals of the specific needs of veterans. These schemes provide support to ensure appropriate signposting and referrals to relevant veteran and wider services within the National Health Service.In May 2025, a national training and education plan was announced to help veterans benefit from improved and targeted healthcare. NHS staff across England will receive dedicated training to help them identify and support patients with military backgrounds. This will be rolled out across the NHS from 1 October 2025.

What steps he is taking to (a) improve mental health services and (b) reduce the rate of suicide in (i) England and (ii) Romford constituency.

NHS North East London Integrated Care Board is responsible for commissioning services to meet the mental health needs of people in Romford.Nationally, the Government is investing an extra £688 million this year to transform mental health services by hiring more staff, delivering more early interventions and talking therapies and getting waiting lists down.We are delivering on our commitment to recruit an additional 8,500 staff across children and adult mental health services by the end of the Parliament and 6,700 of these extra workers have been recruited since July 2024. And our Mental Health Bill, which has completed its committee stage in this House, will modernise the Mental Health Act and make it fit for the 21st century.The 10-Year Health Plan sets out ambitious plans to boost mental health support across the country so that the right people get the right support at the right time. We are transforming mental health services into neighbourhood mental health centres that operate 24 hours a day, seven days a week, improving assertive outreach and giving patients better access to round-the-clock support directly through the NHS App, including self-referral for talking therapies.

What steps he has taken to improve health outcomes for homeless people.

The Government is committed to building a fairer Britain by tackling the structural inequalities that contribute to poor health, particularly for disadvantaged groups, including those experiencing homelessness. We recognise the importance of reducing barriers to healthcare services for those experiencing homelessness. This is why we supported the development and implementation of National Institute for Health and Care Excellence guidance, code NG214, which provides recommendations on ways to improve access to, and engagement with, health and social care services for people experiencing homelessness. This guidance is available at the following link:https://www.nice.org.uk/guidance/ng214The Department has recently published a progressive 10-Year Health Plan. We are committed to reducing the gap in healthy life expectancy between the richest and poorest, an ambitious commitment that shows that the Government is serious about tackling health inequalities and addressing the social determinants of health.

What recent assessment his Department has made of the adequacy of the scientific evidence underpinning the prohibition of kava-kava under the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002.

The UK Statutory Instrument 2002 No. 3170 The Medicines for Human use (Kava-kava) (Prohibition) Order 2002 prohibits the sale, supply, and importation of Kava-kava for use in unlicensed medicines in the United Kingdom. The Prohibition Order was reviewed after it had been in force for two years by an Expert Working Group of the Committee on Safety of Medicines, which announced in February 2006 that the prohibition was justified and proportionate and should remain in place. No further review of the prohibition order has been made. The 2002 Prohibition Order does not exclude applicants applying for a traditional herbal registration or a marketing authorisation under Regulation 125 or Regulation 49, respectively, of the Human Medicines Regulations 2012. Should a traditional herbal registration or a marketing authorisation application for a Kava-kava medicinal product be submitted to the Medicines Healthcare products Regulatory Agency, its safety would be reviewed on an application-specific basis and based on the currently available evidence.

Whether his Department has received any representations from (a) medical and (b) ethnobotanical researchers on the potential therapeutic uses of Kava since 2020.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines, medical devices, and blood components for transfusion in the United Kingdom, this includes the regulation of herbal medicinal products.The MHRA received requests in 2023 and 2024 to reconsider or remove Kava-kava from the UK’s list of restricted or banned herbal products, in order to allow the traditionally prepared beverage containing Kava-kava, used medicinally to treat anxiety and insomnia, to be marketed in the UK.The MHRA indicated that an application for a marketing authorisation or a traditional herbal registration would be required to place any medicinal product on the UK market, and provided information about the requirements. Applications for authorised products are exempt from the Statutory Instrument 2002 No. 3170 The Medicines for Human use (Kava-kava) (Prohibition) Order 2002. However, no application has been received by the MHRA.

Whether his Department plans to review the prohibition on the (a) import and (b) sale of Kava products.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines, medical devices, and blood components for transfusion in the United Kingdom, and this includes the regulation of herbal medicinal products.The UK Statutory Instrument 2002 No. 3170 The Medicines for Human use (Kava-kava) (Prohibition) Order 2002 prohibits the sale, supply, and importation of Kava-kava for use in unlicensed medicines in the UK. The Prohibition Order was reviewed after it had been in force for two years by an Expert Working Group of the Committee on Safety of Medicines, which announced in February 2006 that the prohibition was justified and proportionate and should remain in place. No further review of the prohibition order has been made. The 2002 Prohibition Order does not exclude applicants applying for a traditional herbal registration or a marketing authorisation under Regulation 125 or Regulation 49, respectively, of the Human Medicines Regulations 2012, should someone wish to market a Kava-kava medicinal product in the UK.

What steps he has taken to work with relevant authorities to reduce the number of allergy related deaths in (a) England and (b) Romford constituency.

The Department works with various other Government departments, agencies, and other organisations to improve allergy care and outcomes and, ultimately, to reduce the number of allergy related deaths, including for people in Romford constituency.The Expert Advisory Group on Allergy (EAGA) is jointly chaired by the Department, and includes representation from NHS England, relevant Government departments and agencies, and professional organisations and patient groups. The EAGA's purpose is to identify priority areas for policy change and development related to allergy care, and to advise on how to achieve improved outcomes for people with allergies. This includes identifying areas for the Department, NHS England, and other Government departments and agencies to focus attention on.Outside the EAGA, the Department collaborates with other Government departments and agencies on allergy policy to address the wide-ranging impact of allergies that can extend beyond healthcare to areas like education and food safety. This includes work with the Department for Education to ensure that schools have appropriate measures in place to support pupils with allergies, and with the Food Standards Agency to ensure that individuals with food allergies have access to safe food and are well-informed about potential allergens in the food they consume.This cross-Departmental approach is essential for developing comprehensive strategies that address the various challenges presented by allergies, including prevention, management, and the impact on individuals' quality of life.

What assessment he has made of the potential merits of an alternative to staging when measuring early diagnosis for (a) blood cancers and (b) other unstageable cancers.

There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. To tackle late diagnoses of blood cancers, the National Health Service is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. Blood cancers are one of the most common cancer types diagnosed through these pathways.It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will get the NHS diagnosing blood cancer earlier and treating it faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.  The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates.

What comparative assessment he has made of trends in the level of late diagnosis of (a) blood cancers and (b) solid tumour cancers.

There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. To tackle late diagnoses of blood cancers, the National Health Service is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. Blood cancers are one of the most common cancer types diagnosed through these pathways.It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will get the NHS diagnosing blood cancer earlier and treating it faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.  The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates.

What plans he has to ensure early diagnosis targets in cancer can be (a) measured and (b) monitored for (i) blood cancers and (ii) other unstageable cancers.

There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. To tackle late diagnoses of blood cancers, the National Health Service is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. Blood cancers are one of the most common cancer types diagnosed through these pathways.It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will get the NHS diagnosing blood cancer earlier and treating it faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.  The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates.

What progress his Department has made towards Smokefree 2030.

Smokefree 2030 was Government policy prior to and until the July 2024 General Election. The landmark Tobacco and Vapes Bill will help deliver our current ambition to create a smoke-free generation, gradually ending the sale of tobacco products across the country. Creating a smoke-free generation is expected to help reduce smoking rates of people aged between 14 and 30 years old to near zero by 2050.To support current smokers, an additional £70 million is also being provided in 2025/26 to support local authority-led Stop Smoking Services in England, and the national Swap to Stop scheme, swapping cigarettes for vapes, and Smoke-free Pregnancy Incentives Scheme are also continuing.

What steps he is taking with relevant authorities to help prevent alcohol-related deaths in (a) Romford constituency and (b) England.

The increase in alcohol related deaths and those linked to cocaine usage is concerning. The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment to reduce the numbers of alcohol and drug related deaths. Local authorities are responsible for assessing the local need for alcohol and drug prevention and treatment in their area, and for commissioning services to meet those needs. In addition to the Public Health Grant, in 2025/26, the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment. Havering Borough Council, of which Romford is a part, will receive £400,302 from this additional grant funding in 2025/26.The Department has an action plan in place to reduce drug and alcohol-related deaths, which is currently being reviewed to ensure that it is grounded in the latest understanding of the drivers of drug and alcohol related deaths, and is responding to these. In 2024, the Department published guidance for local authorities and their partnerships on how to review adult drug and alcohol-related deaths and near-fatal overdoses to prevent future deaths.Alongside the funding allocations, the Department has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs to improve treatment outcomes. The commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard can be found at the following link:https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-servicesLater this year the Department will also be publishing the United Kingdom clinical guidelines on alcohol treatment, which will include recommendations on developing effective, accessible, and inclusive services. The aim of the guidelines is to promote and support good practice and improve the quality of service provision, resulting in better outcomes. The Department continues to work with all local areas to address unmet needs and drug and alcohol misuse deaths, and to drive improvements in the continuity of care. This includes the Unmet Need Toolkit, which can be used by local areas to assess local need and plan to meet it.

Whether his Department has made an estimate of the cost to the public purse of making prescriptions free for people with chronic, long-term conditions.

The Department has made no estimate. There are extensive arrangements currently in place in England to ensure that prescriptions are affordable for everyone, including for those with chronic, long-term conditions.Approximately 89% of prescription items are dispensed free of charge in the community in England, and there are a wide range of exemptions from prescription charges already in place, for which those with heart disease may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.People on low incomes can apply for help with their health costs through the NHS Low Income Scheme. The scheme provides income related help to people who are not automatically exempt from charges but who may be entitled to full or partial help if they have a low income and savings below a defined limit.To support those with greatest need who do not qualify for an exemption or the NHS Low Income Scheme, prescription prepayment certificates (PPCs) are available. PPCs allow people to claim as many prescriptions as they need for a set cost, with three month and 12 month certificates available, which can be paid for in instalments.

What steps he is taking with relevant authorities to prevent cocaine-related deaths in (a) Romford constituency and (b) England.

The increase in alcohol related deaths and those linked to cocaine usage is concerning. The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment to reduce the numbers of alcohol and drug related deaths. Local authorities are responsible for assessing the local need for alcohol and drug prevention and treatment in their area, and for commissioning services to meet those needs. In addition to the Public Health Grant, in 2025/26, the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment. Havering Borough Council, of which Romford is a part, will receive £400,302 from this additional grant funding in 2025/26.The Department has an action plan in place to reduce drug and alcohol-related deaths, which is currently being reviewed to ensure that it is grounded in the latest understanding of the drivers of drug and alcohol related deaths, and is responding to these. In 2024, the Department published guidance for local authorities and their partnerships on how to review adult drug and alcohol-related deaths and near-fatal overdoses to prevent future deaths.Alongside the funding allocations, the Department has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs to improve treatment outcomes. The commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard can be found at the following link:https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-servicesLater this year the Department will also be publishing the United Kingdom clinical guidelines on alcohol treatment, which will include recommendations on developing effective, accessible, and inclusive services. The aim of the guidelines is to promote and support good practice and improve the quality of service provision, resulting in better outcomes. The Department continues to work with all local areas to address unmet needs and drug and alcohol misuse deaths, and to drive improvements in the continuity of care. This includes the Unmet Need Toolkit, which can be used by local areas to assess local need and plan to meet it.

What steps he is taking to work with relevant authorities to prevent heat-related deaths in (a) Romford constituency and (b) England.

The UK Health Security Agency’s (UKHSA) Adverse Weather and Health Plan (AWHP) aims to protect everyone from the health effects of adverse weather and to build community resilience. The plan informs local preparedness activities, including in the Borough of Romford. The 2025 to 2026 AWHP is available at the following link:https://assets.publishing.service.gov.uk/media/67fe2667694d57c6b1cf8d3c/AWHP_2025_to_2026.pdfThe plan is supported by a series of guidance materials for stakeholders to prepare for and respond to significant adverse weather events. The heat health alerts provide suggested actions according to the alert level. People can sign up to access the Weather Health Alerts email service at the following link:https://forms.office.com/pages/responsepage.aspx?id=mRRO7jVKLkutR188-d6GZn06Ss-xPLpCuYeyOZ-eFiFUMEVIMDRTOE5FVzFFM0NXNjFMWUlWMkJVMCQlQCN0PWcu

What steps he is taking to increase public awareness of pre-payment certificates as a means to help reduce the cost of prescriptions.

Promotion of pre-payment certificates (PPCs) is carried out by the NHS Business Services Authority (NHSBSA), who promote the use of their online eligibility checker in the first instance, to enable people to check if they are entitled to free prescriptions or the NHS Low Income Scheme, before they purchase a PPC. They undertake PPC-specific communications activity such as:- paid social media adverts, for instance running adverts in 2023/24 and 2024/25 to promote PPCs;- posts on the Help with Health Costs Facebook and X channels promoting PPCs, with about one per week, amongst information about other exemptions;- collaboration with NHS England to run a social media campaign promoting PPCs to people with certain medical conditions that aren’t covered by a medical exemption certificate;- promotion of PPCs to pharmacy teams in a quarterly e-bulletin; and- work with the media to place stories promoting PPCs, which are typically annual data-led media releases.NHSBSA analysis shows that in 2023/24 an estimated 3.3 million patients received a prescription using a PPC, while the number of PPCs issued has steadily risen from approximately 2.29 million in 2018/19 to approximately three million in 2023/24, suggesting growing awareness. Additionally, the hormone replacement therapy PPC was introduced in 2023/24, and 566,000 certificates were issued in its first year.

What steps he is taking with relevant authorities to prevent cold-related deaths in (a) Romford constituency and (b) England.

The UK Health Security Agency’s (UKHSA) Adverse Weather and Health Plan (AWHP) aims to protect everyone from the health effects of adverse weather, and to build community resilience. The plan informs local preparedness activities, including in the Borough of Romford, and is exercised regularly. The 2025 to 2026 AWHP is available at the following link:https://assets.publishing.service.gov.uk/media/67fe2667694d57c6b1cf8d3c/AWHP_2025_to_2026.pdfThe plan is supported by a series of guidance materials to support stakeholders to prepare for and respond to significant adverse weather events. The cold health alerts provide sector specific suggested actions according to the alert level. People can sign up to access the Weather Health Alerts email service at the following link:https://forms.office.com/pages/responsepage.aspx?id=mRRO7jVKLkutR188-d6GZn06Ss-xPLpCuYeyOZ-eFiFUMEVIMDRTOE5FVzFFM0NXNjFMWUlWMkJVMCQlQCN0PWcu

What steps he is taking to support people suffering from drug addiction in Romford constituency.

The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment.Local authorities are responsible for assessing local need for alcohol and drug prevention and treatment in their area, and for commissioning services to meet these needs. In addition to the Public Health Grant, in 2025/26 the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment. Havering Borough Council, of which Romford is a part, will receive £400,302 from this additional grant funding in 2025/26. Further details are available at the following link:https://www.gov.uk/government/publications/drug-and-alcohol-treatment-and-recovery-funding-2025-to-2026/drug-and-alcohol-treatment-and-recovery-funding-allocations-2025-to-2026Alongside the funding allocations, the Department also has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs, to improve treatment outcomes. For example, the commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard can be found at the following link:https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-servicesLater this year the Department will also be publishing the United Kingdom’s clinical guidelines on alcohol treatment. The aim of the guidelines is to improve and support good practice to achieve better outcomes for people with alcohol problems.

What steps his Department is taking to ensure that healthcare professionals in (a) emergency, (b) general and (c) wards receive adequate training related to sickle cell disorder.

Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases, such as sickle cell disorder. This framework sets out four priorities collaboratively developed with the rare disease community, which include increasing awareness of rare diseases among healthcare professionals.NHS England has launched several activities to improve staff knowledge and training aimed at healthcare professionals, including developing the ACT NOW campaign to improve awareness of frontline staff of what to do when people attend hospital in a sickle cell crisis, providing support to specialist staff for sickle cell and thalassemia through the Haemoglobinopathy Coordinating Centre network, and developing free e-learning to help staff, including those in accident and emergency, haematology, and ambulance services, to identify signs of a sickle cell crisis. Further information on the ACT NOW campaign is available at the following link:https://www.england.nhs.uk/london/a-c-t-n-o-w-sickle-cell-acronym-pilot/NHS England is working with clinicians and people with sickle cell disorder in Manchester to understand how to help people to better manage their disorder. The learning from this pilot will be shared nationally, to support others to embed a similar approach to care, that reflects the needs of their local populations.